Saving a trial from running into drug shortage

Saving a trial from running into drug shortage
Topics
Clinical supply chain performance
Clinical supply forecasting & planning
CRO/CDMO
Pharma/Biotech
Simulations & risk-based optimization
Date
July 14, 2023

Although our solutions are ideally used proactively before the start of a trial to ensure a smooth sailing through the trial’s lifecycle, we are sometimes called after a trial starts to help solve all sort of predicaments, including drug shortages.

We recently were called by a small biopharma company 6 months after the initiation of their trial because they were about to run into a drug shortage situation. In this case, we found ourself in a reactive risk management situation and without any hesitation we activated N-SIDE’s risk management method. The process consists of 6 consecutive steps:

  1. Identify the risk
  2. Identify the causes
  3. Find risk mitigation ideas
  4. Prioritize them
  5. Simulate & asses their impact
  6. Implement all the relevant solutions

This image outlines a six-step process for risk management, from identifying risks and causes to finding mitigation ideas, prioritizing, simulating impact, and implementing solutions.

Once the process was activated, we were fast to act and managed to avoid the drug shortage situation without losing a single day. By using our simulation and optimization solutions and collaborating closely with our client, we could jointly choose the best way forward. 

Read the case study now if you want to see how data-driven decisions led to avoid any risk altogether while ensuring neither patients nor timeline were impacted.

Author
Mégane Noirfalise
Mégane Noirfalise
Life Sciences Marketing Coordinator, N-SIDE